ID   SC5A1_HUMAN             Reviewed;         664 AA.
AC   P13866; B2R7E2; B7Z4Q9; B7ZA69;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Sodium/glucose cotransporter 1;
DE            Short=Na(+)/glucose cotransporter 1;
DE   AltName: Full=High affinity sodium-glucose cotransporter;
DE   AltName: Full=Solute carrier family 5 member 1;
GN   Name=SLC5A1; Synonyms=NAGT, SGLT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2490366; DOI=10.1073/pnas.86.15.5748;
RA   Hediger M.A., Turk E., Wright E.M.;
RT   "Homology of the human intestinal Na+/glucose and Escherichia coli
RT   Na+/proline cotransporters.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:5748-5752(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GGM GLY-28.
RX   PubMed=8195156;
RA   Turk E., Martin M.G., Wright E.M.;
RT   "Structure of the human Na+/glucose cotransporter gene SGLT1.";
RL   J. Biol. Chem. 269:15204-15209(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Heart, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   TOPOLOGY, MUTAGENESIS OF ASN-248, AND GLYCOSYLATION AT ASN-248.
RX   PubMed=8567640; DOI=10.1074/jbc.271.4.1925;
RA   Turk E., Kerner C.J., Lostao M.P., Wright E.M.;
RT   "Membrane topology of the human Na+/glucose cotransporter SGLT1.";
RL   J. Biol. Chem. 271:1925-1934(1996).
RN   [8]
RP   VARIANT GGM ASN-28.
RX   PubMed=2008213; DOI=10.1038/350354a0;
RA   Turk E., Zabel B., Mundlos S., Dyer J., Wright E.M.;
RT   "Glucose/galactose malabsorption caused by a defect in the Na+/glucose
RT   cotransporter.";
RL   Nature 350:354-356(1991).
RN   [9]
RP   VARIANTS GGM ARG-318 AND VAL-468.
RX   PubMed=10036327; DOI=10.1016/S0925-4439(98)00109-4;
RA   Lam J.T., Martin M.G., Turk E., Hirayama B.A., Bosshard N.U.,
RA   Steinmann B., Wright E.M.;
RT   "Missense mutations in SGLT1 cause glucose-galactose malabsorption by
RT   trafficking defects.";
RL   Biochim. Biophys. Acta 1453:297-303(1999).
RN   [10]
RP   VARIANT GGM TRP-135.
RX   PubMed=11406349; DOI=10.1016/S0925-4439(01)00043-6;
RA   Kasahara M., Maeda M., Hayashi S., Mori Y., Abe T.;
RT   "A missense mutation in the Na(+)/glucose cotransporter gene SGLT1 in
RT   a patient with congenital glucose-galactose malabsorption: normal
RT   trafficking but inactivation of the mutant protein.";
RL   Biochim. Biophys. Acta 1536:141-147(2001).
CC   -!- FUNCTION: Actively transports glucose into cells by Na(+)
CC       cotransport with a Na(+) to glucose coupling ratio of 2:1.
CC       Efficient substrate transport in mammalian kidney is provided by
CC       the concerted action of a low affinity high capacity and a high
CC       affinity low capacity Na(+)/glucose cotransporter arranged in
CC       series along kidney proximal tubules.
CC   -!- INTERACTION:
CC       P00533:EGFR; NbExp=3; IntAct=EBI-1772443, EBI-297353;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13866-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13866-2; Sequence=VSP_044782;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in intestine and kidney.
CC   -!- PTM: N-glycosylation is not necessary for the cotransporter
CC       function. {ECO:0000269|PubMed:8567640}.
CC   -!- DISEASE: Congenital glucose/galactose malabsorption (GGM)
CC       [MIM:606824]: Intestinal monosaccharide transporter deficiency. It
CC       is an autosomal recessive disorder manifesting itself within the
CC       first weeks of life. It is characterized by severe diarrhea and
CC       dehydration which are usually fatal unless glucose and galactose
CC       are eliminated from the diet. {ECO:0000269|PubMed:10036327,
CC       ECO:0000269|PubMed:11406349, ECO:0000269|PubMed:2008213,
CC       ECO:0000269|PubMed:8195156}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the sodium:solute symporter (SSF)
CC       (TC 2.A.21) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24847; AAA60320.1; -; mRNA.
DR   EMBL; L29339; AAB59448.1; -; Genomic_DNA.
DR   EMBL; L29328; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29330; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29329; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29331; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29332; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29333; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29334; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29335; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29336; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29337; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; L29338; AAB59448.1; JOINED; Genomic_DNA.
DR   EMBL; CR456579; CAG30465.1; -; mRNA.
DR   EMBL; AK297665; BAH12645.1; -; mRNA.
DR   EMBL; AK312948; BAG35789.1; -; mRNA.
DR   EMBL; AK316184; BAH14555.1; -; mRNA.
DR   EMBL; AL022321; CAI19810.1; -; Genomic_DNA.
DR   EMBL; Z74021; CAI19810.1; JOINED; Genomic_DNA.
DR   EMBL; Z80998; CAI19810.1; JOINED; Genomic_DNA.
DR   EMBL; Z83839; CAI19810.1; JOINED; Genomic_DNA.
DR   EMBL; Z83849; CAI19810.1; JOINED; Genomic_DNA.
DR   EMBL; Z74021; CAI18756.1; -; Genomic_DNA.
DR   EMBL; AL022321; CAI18756.1; JOINED; Genomic_DNA.
DR   EMBL; Z80998; CAI18756.1; JOINED; Genomic_DNA.
DR   EMBL; Z83839; CAI18756.1; JOINED; Genomic_DNA.
DR   EMBL; Z83849; CAI18756.1; JOINED; Genomic_DNA.
DR   EMBL; Z80998; CAI18759.1; -; Genomic_DNA.
DR   EMBL; AL022321; CAI18759.1; JOINED; Genomic_DNA.
DR   EMBL; Z74021; CAI18759.1; JOINED; Genomic_DNA.
DR   EMBL; Z83839; CAI18759.1; JOINED; Genomic_DNA.
DR   EMBL; Z83849; CAI18759.1; JOINED; Genomic_DNA.
DR   EMBL; Z83839; CAB06087.1; -; Genomic_DNA.
DR   EMBL; AL022321; CAB06087.1; JOINED; Genomic_DNA.
DR   EMBL; Z74021; CAB06087.1; JOINED; Genomic_DNA.
DR   EMBL; Z80998; CAB06087.1; JOINED; Genomic_DNA.
DR   EMBL; Z83849; CAB06087.1; JOINED; Genomic_DNA.
DR   EMBL; Z83849; CAI23589.1; -; Genomic_DNA.
DR   EMBL; AL022321; CAI23589.1; JOINED; Genomic_DNA.
DR   EMBL; Z74021; CAI23589.1; JOINED; Genomic_DNA.
DR   EMBL; Z80998; CAI23589.1; JOINED; Genomic_DNA.
DR   EMBL; Z83839; CAI23589.1; JOINED; Genomic_DNA.
DR   EMBL; CH471095; EAW60006.1; -; Genomic_DNA.
DR   CCDS; CCDS13902.1; -. [P13866-1]
DR   CCDS; CCDS58805.1; -. [P13866-2]
DR   PIR; A33545; A33545.
DR   RefSeq; NP_000334.1; NM_000343.3. [P13866-1]
DR   RefSeq; NP_001243243.1; NM_001256314.1. [P13866-2]
DR   UniGene; Hs.1964; -.
DR   ProteinModelPortal; P13866; -.
DR   BioGrid; 112414; 2.
DR   IntAct; P13866; 1.
DR   STRING; 9606.ENSP00000266088; -.
DR   BindingDB; P13866; -.
DR   ChEMBL; CHEMBL4979; -.
DR   DrugBank; DB08907; Canagliflozin.
DR   GuidetoPHARMACOLOGY; 915; -.
DR   TCDB; 2.A.21.3.1; the solute:sodium symporter (sss) family.
DR   iPTMnet; P13866; -.
DR   PhosphoSitePlus; P13866; -.
DR   BioMuta; SLC5A1; -.
DR   DMDM; 127803; -.
DR   EPD; P13866; -.
DR   MaxQB; P13866; -.
DR   PaxDb; P13866; -.
DR   PeptideAtlas; P13866; -.
DR   PRIDE; P13866; -.
DR   DNASU; 6523; -.
DR   Ensembl; ENST00000266088; ENSP00000266088; ENSG00000100170. [P13866-1]
DR   Ensembl; ENST00000543737; ENSP00000444898; ENSG00000100170. [P13866-2]
DR   GeneID; 6523; -.
DR   KEGG; hsa:6523; -.
DR   UCSC; uc003amc.4; human. [P13866-1]
DR   CTD; 6523; -.
DR   DisGeNET; 6523; -.
DR   GeneCards; SLC5A1; -.
DR   HGNC; HGNC:11036; SLC5A1.
DR   HPA; CAB015467; -.
DR   HPA; HPA051805; -.
DR   HPA; HPA055106; -.
DR   MalaCards; SLC5A1; -.
DR   MIM; 182380; gene.
DR   MIM; 606824; phenotype.
DR   neXtProt; NX_P13866; -.
DR   OpenTargets; ENSG00000100170; -.
DR   Orphanet; 35710; Glucose-galactose malabsorption.
DR   PharmGKB; PA308; -.
DR   eggNOG; ENOG410IP49; Eukaryota.
DR   eggNOG; COG4146; LUCA.
DR   GeneTree; ENSGT00760000118955; -.
DR   HOVERGEN; HBG052859; -.
DR   InParanoid; P13866; -.
DR   KO; K14158; -.
DR   OMA; KAGCTLC; -.
DR   OrthoDB; EOG091G077U; -.
DR   PhylomeDB; P13866; -.
DR   TreeFam; TF352855; -.
DR   Reactome; R-HSA-189200; Hexose transport.
DR   Reactome; R-HSA-428808; Na+-dependent glucose transporters.
DR   Reactome; R-HSA-429593; Inositol transporters.
DR   ChiTaRS; SLC5A1; human.
DR   GeneWiki; SLC5A1; -.
DR   GenomeRNAi; 6523; -.
DR   PRO; PR:P13866; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100170; -.
DR   CleanEx; HS_SLC5A1; -.
DR   Genevisible; P13866; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005412; F:glucose:sodium symporter activity; IDA:MGI.
DR   GO; GO:0015758; P:glucose transport; IMP:MGI.
DR   GO; GO:0008645; P:hexose transport; TAS:Reactome.
DR   GO; GO:0001951; P:intestinal D-glucose absorption; IBA:GO_Central.
DR   InterPro; IPR001734; Na/solute_symporter.
DR   InterPro; IPR018212; Na/solute_symporter_CS.
DR   Pfam; PF00474; SSF; 1.
DR   TIGRFAMs; TIGR00813; sss; 1.
DR   PROSITE; PS00456; NA_SOLUT_SYMP_1; 1.
DR   PROSITE; PS00457; NA_SOLUT_SYMP_2; 1.
DR   PROSITE; PS50283; NA_SOLUT_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Disulfide bond; Glycoprotein; Ion transport; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Sodium; Sodium transport;
KW   Sugar transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    664       Sodium/glucose cotransporter 1.
FT                                /FTId=PRO_0000105366.
FT   TOPO_DOM      1     28       Extracellular. {ECO:0000255}.
FT   TRANSMEM     29     49       Helical. {ECO:0000255}.
FT   TOPO_DOM     50     64       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     65     85       Helical. {ECO:0000255}.
FT   TOPO_DOM     86    105       Extracellular. {ECO:0000255}.
FT   TRANSMEM    106    126       Helical. {ECO:0000255}.
FT   TOPO_DOM    127    142       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    143    163       Helical. {ECO:0000255}.
FT   TOPO_DOM    164    178       Extracellular. {ECO:0000255}.
FT   TRANSMEM    179    201       Helical. {ECO:0000255}.
FT   TOPO_DOM    202    208       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical. {ECO:0000255}.
FT   TOPO_DOM    230    277       Extracellular. {ECO:0000255}.
FT   TRANSMEM    278    298       Helical. {ECO:0000255}.
FT   TOPO_DOM    299    313       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    314    334       Helical. {ECO:0000255}.
FT   TOPO_DOM    335    380       Extracellular. {ECO:0000255}.
FT   TRANSMEM    381    401       Helical. {ECO:0000255}.
FT   TOPO_DOM    402    423       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    424    444       Helical. {ECO:0000255}.
FT   TOPO_DOM    445    455       Extracellular. {ECO:0000255}.
FT   TRANSMEM    456    476       Helical. {ECO:0000255}.
FT   TOPO_DOM    477    484       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    485    505       Helical. {ECO:0000255}.
FT   TOPO_DOM    506    526       Extracellular. {ECO:0000255}.
FT   INTRAMEM    527    563       Helical. {ECO:0000255}.
FT   TOPO_DOM    564    643       Extracellular. {ECO:0000255}.
FT   TRANSMEM    644    664       Helical. {ECO:0000255}.
FT   BINDING     457    457       Glucose. {ECO:0000250}.
FT   SITE         43     43       Implicated in sodium coupling.
FT                                {ECO:0000250}.
FT   SITE        300    300       Implicated in sodium coupling.
FT                                {ECO:0000250}.
FT   SITE        460    460       Involved in sugar-binding/transport and
FT                                inhibitor binding. {ECO:0000250}.
FT   MOD_RES     587    587       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8C3K6}.
FT   CARBOHYD    248    248       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:8567640}.
FT   DISULFID    255    610       {ECO:0000250}.
FT   VAR_SEQ       1    127       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044782.
FT   VARIANT      28     28       D -> G (in GGM; dbSNP:rs121912669).
FT                                {ECO:0000269|PubMed:8195156}.
FT                                /FTId=VAR_013630.
FT   VARIANT      28     28       D -> N (in GGM; dbSNP:rs121912668).
FT                                {ECO:0000269|PubMed:2008213}.
FT                                /FTId=VAR_007168.
FT   VARIANT      51     51       N -> S (in dbSNP:rs17683011).
FT                                /FTId=VAR_029147.
FT   VARIANT     135    135       R -> W (in GGM; loss of activity).
FT                                {ECO:0000269|PubMed:11406349}.
FT                                /FTId=VAR_021502.
FT   VARIANT     318    318       G -> R (in GGM; dbSNP:rs371505974).
FT                                {ECO:0000269|PubMed:10036327}.
FT                                /FTId=VAR_021503.
FT   VARIANT     411    411       A -> T (in dbSNP:rs17683430).
FT                                /FTId=VAR_029148.
FT   VARIANT     468    468       A -> V (in GGM; dbSNP:rs200406921).
FT                                {ECO:0000269|PubMed:10036327}.
FT                                /FTId=VAR_021504.
FT   MUTAGEN     248    248       N->Q: Loss of N-glycosylation.
FT                                {ECO:0000269|PubMed:8567640}.
FT   CONFLICT    631    631       K -> R (in Ref. 4; BAH14555).
FT                                {ECO:0000305}.
SQ   SEQUENCE   664 AA;  73498 MW;  2B403376595EAB74 CRC64;
     MDSSTWSPKT TAVTRPVETH ELIRNAADIS IIVIYFVVVM AVGLWAMFST NRGTVGGFFL
     AGRSMVWWPI GASLFASNIG SGHFVGLAGT GAASGIAIGG FEWNALVLVV VLGWLFVPIY
     IKAGVVTMPE YLRKRFGGQR IQVYLSLLSL LLYIFTKISA DIFSGAIFIN LALGLNLYLA
     IFLLLAITAL YTITGGLAAV IYTDTLQTVI MLVGSLILTG FAFHEVGGYD AFMEKYMKAI
     PTIVSDGNTT FQEKCYTPRA DSFHIFRDPL TGDLPWPGFI FGMSILTLWY WCTDQVIVQR
     CLSAKNMSHV KGGCILCGYL KLMPMFIMVM PGMISRILYT EKIACVVPSE CEKYCGTKVG
     CTNIAYPTLV VELMPNGLRG LMLSVMLASL MSSLTSIFNS ASTLFTMDIY AKVRKRASEK
     ELMIAGRLFI LVLIGISIAW VPIVQSAQSG QLFDYIQSIT SYLGPPIAAV FLLAIFWKRV
     NEPGAFWGLI LGLLIGISRM ITEFAYGTGS CMEPSNCPTI ICGVHYLYFA IILFAISFIT
     IVVISLLTKP IPDVHLYRLC WSLRNSKEER IDLDAEEENI QEGPKETIEI ETQVPEKKKG
     IFRRAYDLFC GLEQHGAPKM TEEEEKAMKM KMTDTSEKPL WRTVLNVNGI ILVTVAVFCH
     AYFA
//
